{"schema_version":"secwatch.filing_event.v1","accession":"0001607062-22-000013","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2022-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.232239+00:00","generated_at":"2026-06-27T17:57:08.354195+00:00","sec_items":["2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Regen Biopharma subleases office space from BST Partners controlled by CEO David Koos at $5,000/month","bullets":["Entered into month-to-month sublease with BST Partners for office space at 4700 Spring Street, Suite 304, La Mesa, CA starting January 14, 2022.","Monthly rent of $5,000 payable to BST Partners, which is controlled by David Koos, Regen's sole officer and director.","Sublease creates a direct financial obligation and is a related-party transaction due to Koos's control of both entities."],"urls":{"canonical":"https://secwatch.observer/filing/0001607062-22-000013","json":"https://secwatch.observer/filing/0001607062-22-000013.json","markdown":"https://secwatch.observer/filing/0001607062-22-000013.md","text":"https://secwatch.observer/filing/0001607062-22-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/0001607062-22-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/rgbp011322form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:57:08.354195+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}